Please login to the form below

Not currently logged in
Email:
Password:

pSivida Strengthens board with new non-executive director

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Australia-headquartered drug delivery company pSivida has hired Dr Katherine Woodthorpe as a non-executive director.

Dr Woodthorpe is CEO of AVCAL (Australian Private Equity and Venture Capital Association) and has an extensive background as a management adviser and director, including working with Australian technology companies seeking venture funding to being a board member of listed companies. She has also consulted with government groups on innovation and commercialisation.

Woodthorpe is also chair of the Antarctic Climate and Ecosystems Cooperative Research Centre, director of Insearch and a council member of the University of Technology Sydney.

pSivida's managing director, Dr Paul Ashton, said: "We are very fortunate to have Katherine join the board. Katherine brings a unique and powerful blend of scientific and business skills that we believe will greatly assist pSivida."

Prior to AVCAL, Woodthorpe worked as a professional non-executive director and management adviser. Her areas of expertise included developing strategies for rapid growth and commercialization of technology products and services.

Stephen Lake, who joined pSivida's board in July 2004 decided to stand down as a director to focus on the launch of a new technology fund in the UK.

6th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics